Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
2,804,515
-
Share change
-
-836,229
-
Total reported value
-
$11,249,000
-
Put/Call ratio
-
216%
-
Price per share
-
$4.01
-
Number of holders
-
31
-
Value change
-
-$3,546,474
-
Number of buys
-
16
-
Number of sells
-
19
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2021
As of 30 Sep 2021 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,804,515 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Manatuck Hill Partners, LLC, COOPERMAN LEON G, GEODE CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, NORTHERN TRUST CORP, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 31 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.